Pentoxifylline attenuates cardiac dysfunction and reduces TNF-alpha level in ischemic-reperfused heart. - Wikidata - wikimedia - TriplyDB

Pentoxifylline attenuates cardiac dysfunction and reduces TNF-alpha level in ischemic-reperfused heart.

Pentoxifylline attenuates cardiac dysfunction and reduces TNF-alpha level in ischemic-reperfused heart.

http://www.wikidata.org/entity/Q46440282

about

Pentoxifylline for vascular health: a brief review of the literature Nutritional and anti-inflammatory interventions in chronic heart failure.Effect of pentoxifylline on preventing acute kidney injury after cardiac surgery by measuring urinary neutrophil gelatinase - associated lipocalin.The effects of pentoxifylline administration on NFΚB P50 transcription factor expression.Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: new evidence on the potential therapeutic mechanism The cardioprotective potential of valsartan in myocardial ischaemia reperfusion injury.Targeting platelets for prevention and treatment of cardiovascular disease.Effects of thyroid hormone analogue and a leukotrienes pathway-blocker on reperfusion injury attenuation after heart transplantation.Antiapoptotic effect of simvastatin ameliorates myocardial ischemia/reperfusion injury.Effects of pentoxifylline on renal structure after urethral obstruction in rat: A stereological study.Both castration and goserelin acetate ameliorate myocardial ischemia reperfusion injury and apoptosis in male rats.The role of ischemic preconditioning and pentoxifylline in intestinal ischemia/reperfusion injury of rats.Unravelling the antimetastatic potential of pentoxifylline, a methylxanthine derivative in human MDA-MB-231 breast cancer cells.Pentoxifylline decreases soluble CD40 ligand concentration and CD40 gene expression in coronary artery disease patients.TNF-alpha-mediated signal transduction pathway is a major determinant of apoptosis in dilated cardiomyopathy.Role of tumour necrosis factor-alpha and other cytokines in ischemia-reperfusion-induced injury in the heart.Evaluation of buspirone on streptozotocin induced type 1 diabetes and its associated complications.Effect of Pentoxifylline on Ischemia- induced Brain Damage and Spatial Memory Impairment in Rat.Strategies for the regulation of intracellular calcium in ischemic heart disease.TNF-alpha blockade decreases oxidative stress in the paraventricular nucleus and attenuates sympathoexcitation in heart failure rats.

P2860

Q26766371-15EB7D9B-0B42-4598-BAEB-5344CF8C757F Q33880185-0AF062B1-6566-4CCA-805C-4A7CE54D7373 Q34567132-AAEB7118-AF6F-4120-846F-F75396ECDB63 Q36144610-E4CA5DD4-ABB5-4A88-9D53-959EB8071534 Q36199008-D7A92158-2041-4FBA-8752-9A01FC68D1D0 Q36260872-8211CE55-2704-47CA-A72E-8CFD37E913D1 Q37004721-259DFB4D-D7E7-4CAE-A39D-449AAFA20F82 Q37217891-8916B576-EDCA-47ED-A546-623137365514 Q37433223-2F98AA78-0DBC-447D-8A65-E8D937B362BA Q37579021-06596A3C-5D25-4CEF-8A3F-3697501F98CF Q37650499-0C22282F-B018-4568-B45D-D79155946963 Q38632210-B85306D9-6DA0-4951-8F85-E8023792C0D7 Q39513395-B97C89A4-69F6-4379-818C-BF2CE04FA1FD Q39697415-5340F0BB-3D83-46C9-B64D-343F4DCA13FC Q41779490-A6548727-3EC8-4B24-96A0-F867920DF4DD Q41824383-D57FF18E-3121-4239-B07F-D19A9877481A Q41921965-793739C1-6984-454D-A34C-4A7897875473 Q43236580-520ADFC1-20DE-4D1B-97A0-023BDA11AB33 Q45168252-C1E50E70-573A-4213-BE68-097313C85D8C Q48212660-26673088-D479-4ED0-990E-ED8FD374A564

P2860

Pentoxifylline attenuates cardiac dysfunction and reduces TNF-alpha level in ischemic-reperfused heart.

http://www.wikidata.org/entity/Q46440282

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Pentoxifylline attenuates card ...... in ischemic-reperfused heart.

@en

Pentoxifylline attenuates card ...... in ischemic-reperfused heart.

@nl

type

label

Pentoxifylline attenuates card ...... in ischemic-reperfused heart.

@en

Pentoxifylline attenuates card ...... in ischemic-reperfused heart.

@nl

prefLabel

Pentoxifylline attenuates card ...... in ischemic-reperfused heart.

@en

Pentoxifylline attenuates card ...... in ischemic-reperfused heart.

@nl

P1433

Q46440282-CD6FC105-5A44-4E5D-9891-64A032C7C814

P1476

Q46440282-AB6830AF-F096-48BC-9DED-25CF3846E074

P2093

Q46440282-01BC892B-E6A3-450D-820C-72FC3674E6BF

Q46440282-105C2846-64E0-4F46-A9A1-451B25E8A0D6

Q46440282-534715C7-D638-4E63-9F70-4F0E0A4AFD96

Q46440282-DAF63F65-FAC2-4AC5-BE15-C2D6A780B2A9

Q46440282-DB6E4E28-557F-40DF-A0D5-BD6EA274B20B

Q46440282-FE4CD099-4024-4726-9F6D-DA5AB7CAE3B6

P2860

Q46440282-11AA71A9-B19D-4616-9BE9-11D99C7D2D7A

Q46440282-1BBBE553-B158-4ED7-88EC-276787F204D4

Q46440282-37BC68A8-DEA9-4A2B-8112-52B3A1F9529F

Q46440282-4451F0CE-1A7A-4BCA-9FDE-2A4F7C0D9780

Q46440282-47656BD8-24C1-40B4-AB1D-978E6B3574B1

Q46440282-48E1B941-7A40-4463-9F95-CE2819CF9AC0

Q46440282-5653FBD7-08D8-4336-97C4-22094D7FAE25

Q46440282-5997A393-0C73-42D0-BF40-50B4531D26AD

Q46440282-5FDD7567-E7B7-4867-8A29-87A3C27D9659

Q46440282-657EDA0A-D87C-4839-AD5B-2EEC6DCE901E

P304

Q46440282-133AB2CE-00F0-4286-B412-93868735B678

P31

Q46440282-2FCA0338-ADCC-4AD9-8EB5-DC6F2AEF6E15

P356

Q46440282-AB4214E7-D3CB-44E6-8E16-35B2AF21D913

P433

Q46440282-CD87D936-697F-4CD3-98B2-46147D868E7D

P478

Q46440282-04A08373-317B-461B-B5BF-2211FC623EED

P577

Q46440282-12850D9E-F41E-4D0E-86C3-2FD504CCB2B2

P698

Q46440282-3C28B6E5-1831-4837-A60D-F157EEC2CAC7

P921

Q46440282-9FE85CA4-EB57-4CE1-B71D-848932788100

P356

AJPHEART.00178.2005

P1433

American Journal of Physiology - Heart and Circulatory Physiology

P1476

Pentoxifylline attenuates card ...... in ischemic-reperfused heart.

@en

P2093

Belma Turan

http://www.w3.org/2001/XMLSchema#string

Harjot K Saini

http://www.w3.org/2001/XMLSchema#string

Ming Zhang

http://www.w3.org/2001/XMLSchema#string

Naranjan S Dhalla

http://www.w3.org/2001/XMLSchema#string

Peter P Liu

http://www.w3.org/2001/XMLSchema#string

Yan-Jun Xu

http://www.w3.org/2001/XMLSchema#string

P2860

Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol: results of a randomized study.

Molecular and cellular mechanisms of myocardial stunning.

Status of myocardial antioxidants in ischemia-reperfusion injury.

Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy.

Inflammatory cytokines and postmyocardial infarction remodeling.

Tumor necrosis factor-alpha in cardiovascular biology and the potential role for anti-tumor necrosis factor-alpha therapy in heart disease.

Inhibition by pentoxifylline of TNF-alpha-stimulated fractalkine production in vascular smooth muscle cells: evidence for mediation by NF-kappa B down-regulation.

Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death.

Infarct size and nitric oxide synthase in murine myocardium.

Pentoxifylline attenuates pulmonary macromolecular leakage after intestinal ischemia-reperfusion.

P304

H832-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPHEART.00178.2005

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

289

http://www.w3.org/2001/XMLSchema#string

P577

2005-04-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15833806

http://www.w3.org/2001/XMLSchema#string

P921